Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
REVIEW ARTICLE  
[LN]

 Article Access Statistics
    Viewed2791    
    Printed164    
    Emailed4    
    PDF Downloaded8    
    Comments [Add]    

Recommend this journal

Biologically based strategies to augment rotator cuff tears


1 Department of Orthopaedic Surgery and Traumatology, Inselspital, Bern, Switzerland,
2 Department of Orthopaedic Surgery and Traumatology, Inselspital; Institute of Immunology, University of Bern, Bern, Switzerland,
3 Department of Orthopaedic Surgery and Sports Traumatology, University of Nice Sophia Antipolis, Nice, France,
4 Department of Orthopaedic Surgery and Traumatology, Inselspital, Bern, Switzerland; Department of Orthopaedic Surgery and Sports Traumatology, University of Nice Sophia Antipolis, Nice, France,

Correspondence Address:
M A Zumstein
Orthopedic Sports Medicine, Department of Orthopaedics and Traumatology, University of Bern, Bern, Switzerland

Login to access the Email id

Source of Support: None, Conflict of Interest: None


Get Permissions

Get Permissions

Year : 2012  |  Volume : 6  |  Issue : 2  |  Page : 51-60

 

SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (923 KB)
Email article
Print Article
Add to My List
Lesions of the rotator cuff (RC) are among the most frequent tendon injuries. In spite of the developments in both open and arthroscopic surgery, RC repair still very often fails. In order to reduce the failure rate after surgery, several experimental in vitro and in vivo therapy methods have been developed for biological improvement of the reinsertion. This article provides an overview of the current evidence for augmentation of RC reconstruction with growth factors. Furthermore, potential future therapeutic approaches are discussed. We performed a comprehensive search of the PubMed database using various combinations of the keywords "tendon," "rotator cuff," "augmentation," "growth factor," "platelet-rich fibrin," and "platelet-rich plasma" for publications up to 2011. Given the linguistic capabilities of the research team, we considered publications in English, German, French, and Spanish. We excluded literature reviews, case reports, and letters to the editor.






[FULL TEXT] [PDF]*
 

 


 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 REVIEW ARTICLE
 




1 Department of Orthopaedic Surgery and Traumatology, Inselspital, Bern, Switzerland,
2 Department of Orthopaedic Surgery and Traumatology, Inselspital; Institute of Immunology, University of Bern, Bern, Switzerland,
3 Department of Orthopaedic Surgery and Sports Traumatology, University of Nice Sophia Antipolis, Nice, France,
4 Department of Orthopaedic Surgery and Traumatology, Inselspital, Bern, Switzerland; Department of Orthopaedic Surgery and Sports Traumatology, University of Nice Sophia Antipolis, Nice, France,

Correspondence Address:
M A Zumstein
Orthopedic Sports Medicine, Department of Orthopaedics and Traumatology, University of Bern, Bern, Switzerland

Login to access the Email id

Source of Support: None, Conflict of Interest: None


Get Permissions

Get Permissions

Lesions of the rotator cuff (RC) are among the most frequent tendon injuries. In spite of the developments in both open and arthroscopic surgery, RC repair still very often fails. In order to reduce the failure rate after surgery, several experimental in vitro and in vivo therapy methods have been developed for biological improvement of the reinsertion. This article provides an overview of the current evidence for augmentation of RC reconstruction with growth factors. Furthermore, potential future therapeutic approaches are discussed. We performed a comprehensive search of the PubMed database using various combinations of the keywords "tendon," "rotator cuff," "augmentation," "growth factor," "platelet-rich fibrin," and "platelet-rich plasma" for publications up to 2011. Given the linguistic capabilities of the research team, we considered publications in English, German, French, and Spanish. We excluded literature reviews, case reports, and letters to the editor.






[FULL TEXT] [PDF]*


        
Print this article     Email this article